Healthcare -
Biotechnology - NASDAQ - US
$ 7.83
0.643 %
$ 1.23 B
Market Cap
-6.07
P/E
OCUL - COST OF REVENUE
Cost of Revenue OCUL - Ocular Therapeutix, Inc.
5.28 M
LAST VALUE
9.48%
2 YEAR CAGR
62.57%
5 YEAR CAGR
-6.66%
10 YEAR CAGR